#AACR26 #DiviTum cell proliferation

Are you looking for a biomarker to support your oncology drug development?

Let’s connect and discuss how TKa can support your oncology drug development programs.

Read more: https://loom.ly/YwGCpo8

DiviTum®TKa is FDA 510(k) cleared and is available as RUO.

#AACR26 #Oncology #Biomarkers #DiviTum

#bscm #divitum #breastoncology @onclive

We are excited about the strong DiviTum TKa results recently published in JCO Precision Oncology!

The study highlights the potential of longitudinal TKa monitoring in MBC and early BC to support treatment decisions.
Read more:: https://loom.ly/Wd6gNxY

#bscm #divitum #breastoncology #rosswellpark

New data from Yale School of Medicine! 🎉

At #SABCS25?

On Dec 10th, 5-6:30 PM CST, hear Dr. Mariya Rozenblit present.

Read the Abstract PS2-09-28: https://loom.ly/Wxy5NX8
Read about the biomarker here: https://loom.ly/tAJuUX0

#biomarker #personalizedmedicine #divitum #bscm

New data from MGB Cancer Institute! 🎉

At #SABCS25?

On Dec 10th, 5-6:30 PM CST, hear Dr. Elena Michaels present.

Read the Abstract PS2-10-21: https://loom.ly/Wxy5NX8
Read about the biomarker here: https://loom.ly/tAJuUX0

#biomarker #personalizedmedicine #divitum #bscm

We’re excited to introduce the team representing us at #SABCS25!

They look forward to discussing our latest work with TKa—the biomarker that measures cell proliferation—incl. the poster presentations on Dec, 10th.

Submit your request to meet: ttps://loom.ly/1JqZvKA

#biomarker #bscm #divitum

We are proud that our SVP Hanna Ritzén is presenting at the upcoming 18th European Bioanalysis Forum.

On November 18th, 2025. Join her at 11:10 AM local time.

Read more about our biomarker DiviTum TKa here: https://loom.ly/c__nywg

#EBF2025 #bioanalysisforum #divitum #precesionmedicine #oncology